| 注册
首页|期刊导航|中国康复理论与实践|咯利普兰治疗大鼠脊髓横断损伤的实验研究

咯利普兰治疗大鼠脊髓横断损伤的实验研究

李锋涛 程斌 李浩鹏 臧全金 张廷 贺西京

中国康复理论与实践Issue(7):628-630,3.
中国康复理论与实践Issue(7):628-630,3.DOI:10.3969/j.issn.1006-9771.2013.07.009

咯利普兰治疗大鼠脊髓横断损伤的实验研究

Effects of Rolipram on Spinal Cord Transection Injury in Rats

李锋涛 1程斌 2李浩鹏 1臧全金 1张廷 1贺西京1

作者信息

  • 1. 西安交通大学第二附属医院,骨二科,陕西西安市710004
  • 2. 西安交通大学第二附属医院,骨三科,陕西西安市710004
  • 折叠

摘要

Abstract

Objective To investigate the possibility of rolipram for treatment of spinal cord injury (SCI) in rats. Methods 30 adult fe-male Sprague-Dawley rats were divided into sham-operation group (sham group, n=10), spinal cord injury group (SCI group, n=10) and ro-lipram treatment group (R group, n=10). The rats in SCI group and R group were modeled as spinal cord transection injury, and R group was administrated with rolipram subcutaneouly after SCI. They were assessed with Basso Beattie and Bresnahan (BBB) score 2, 4, 6, and 8 weeks after SCI, and the expressions of growth associated protein 43 (GAP-43) and glial fibrillary acidic protein (GFAP) were detected with immunohistochemistry 2 weeks after SCI. Results There were significant difference in the BBB scores between SCI and R groups 6 and 8 weeks after SCI (P<0.05). The expression of GAP-43 was more and GFAP was less in R group than in SCI group (P<0.05). Conclusion Ro-lipram can increase the expression of GAP-43 and inhibit the expression of GFAP, while improves the the motor function in rats after spinal cord transsection injury.

关键词

脊髓损伤/咯利普兰/运动功能/生长相关蛋白43/胶质细胞酸性蛋白/大鼠

Key words

spinal cord injury/rolipram/motor function/growth associated protein 43/glial fibrillary acidic protein/rats

分类

医药卫生

引用本文复制引用

李锋涛,程斌,李浩鹏,臧全金,张廷,贺西京..咯利普兰治疗大鼠脊髓横断损伤的实验研究[J].中国康复理论与实践,2013,(7):628-630,3.

中国康复理论与实践

OA北大核心CSCDCSTPCD

1006-9771

访问量0
|
下载量0
段落导航相关论文